A 12-Week Study in Participants With Refractory Chronic Cough (MK-7264-012)
Clinical trial NCT02612610 · COMPLETED
Trial details
- NCT number
- NCT02612610
- Sponsor
- Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-15
- Primary completion
- 2016-10-31
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.